Edition:
United States

dorsaVi Ltd (DVL.AX)

DVL.AX on Australia Stock Exchange

0.44AUD
24 Apr 2017
Change (% chg)

$0.00 (+1.16%)
Prev Close
$0.43
Open
$0.44
Day's High
$0.44
Day's Low
$0.44
Volume
235
Avg. Vol
65,472
52-wk High
$0.60
52-wk Low
$0.25

Latest Key Developments (Source: Significant Developments)

dorsaVi Ltd signs three year agreement
Sunday, 27 Sep 2015 07:35pm EDT 

dorsaVi Ltd:Signed a multimillion dollar deal with a UK physiotherapy network YourPhysioPlan to market and sell ViMove in the United Kingdom and Ireland.The three year deal includes minimum sales targets of 100, 300 and 600 ViMove units to be purchased or leased consecutively each year over this period. If minimum sales targets are achieved, the deal is valued at more than A$9 mln over the three years.Under the agreement, dorsaVi has the right to exit the contract if the minimum sales targets.  Full Article

dorsaVi Ltd raised A$4 mln through institutional placement
Tuesday, 25 Aug 2015 07:06pm EDT 

dorsaVi Ltd:Institutional placement and non-renounceable rights offer.Says has raised a total of A$4 million.Says capital raising by way of placement of 15.4 million ordinary shares at A$0.26 per share.  Full Article

dorsaVi Ltd signs contract with Design Inc
Sunday, 23 Aug 2015 08:02pm EDT 

dorsaVi Ltd:DorsaVi signs international achitecture firm, Designinc.Says three year deal will see dorsaVi work across the review and maintenance of the integrated management system.  Full Article

dorsaVi says signs crown resorts
Sunday, 16 Aug 2015 03:07pm EDT 

dorsaVi Ltd:Says announced the signing of its fourth contract with crown resorts.  Full Article

dorsaVi Ltd announces resignation of Jerome Whelan as CFO
Tuesday, 14 Jul 2015 07:32pm EDT 

dorsaVi Ltd:Says resignation of chief financial office.Says Jerome Whelan, chief financial officer, has tendered his resignation from the company.  Full Article

Clinical trial using dorsaVi sensors demonstrates reduction in back pain
Sunday, 31 May 2015 09:33pm EDT 

dorsaVi Ltd:Demonstrates that back pain patients monitored and treated using wearable movement sensors from dorsaVi Ltd had a sustained improvement in pain and functional ability.Says across all primary outcome measures, participants treated with the dorsaVi sensors with biofeedback showed a 35 pct to 47 pct improvement at 12 months, which were all above the threshold for clinically important difference (>30 pct of baseline scores).  Full Article

FDA approves dorsaVi Ltd's ViMove for expanded use in United States
Sunday, 31 May 2015 08:03pm EDT 

dorsaVi Ltd:Says that it has received 510(k) clearance by US Food and Drug Administration expanding use of ViMove in United States.Says expanded functionality and labelling is significant because for first time in US it permits use of ViMove to display lower back and pelvic range of motion from healthy patients (normative data).  Full Article

dorsaVi Ltd secures London Underground and VINCI Construction as first UK occupational health and safety customers
Wednesday, 20 May 2015 07:57pm EDT 

dorsaVi Ltd:Says signing of its first two UK-based occupational health and safety (OHS) customers: London Underground and VINCI Construction UK Ltd.Says commercial details of contracts are confidential.  Full Article

dorsaVi Ltd signs first OHS deal in the US with Caterpillar Inc.
Wednesday, 6 May 2015 09:01pm EDT 

dorsaVi Ltd:Says that it has secured its first OHS contract within United States with construction and mining equipment manufacturer, Caterpillar Inc.Says Caterpillar's seals metal casting facility in Toccoa, Georgia, will use dorsaVi's OHS wearable sensor technology, ViSafe, to evaluate and define best practice for workers using heavy material handling equipment.  Full Article

More From Around the Web